Article
Relapse of acute promyelocytic leukemia with PML-RARalpha mutant subclones independent of proximate all-trans retinoic acid selection pressure.
Leukemia - 1 Apr 2006
Gallagher R E, Schachter-Tokarz E L, Zhou D-C, Ding W, Kim S H, Sankoorikal B J, Bi W, Livak K J, Slack J L, Willman C L
Abstract excerpt
Relapse of acute promyelocytic leukemia (APL) following all-trans retinoic acid (ATRA) therapy has been associated with the acquisition of mutations in the high-affinity ATRA binding site in PML-RARalpha, but little information is available about the selection dynamics of the mutation-harboring subclones. In this study, 6/18 patients treated with sequential ATRA and chemotherapy on protocol INT0129 relapsed with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
